Cancer: Medical Treatments
Commons · Question 3790 · Tabled 2 Sep 2024 · Department of Health and Social Care · Official record
Answered 11 Sep 2024
Question
Asked by Daisy Cooper
To ask the Secretary of State for Health and Social Care, how many myeloma patients are receiving a fourth line treatment; and what proportion of those patients are being treated with isatuximab in combination with pomalidomide and dexamethasone.
Answer
Answered by Karin Smyth, 11 Sep 2024
Information on the number of myeloma patients receiving a fourth line treatment is not held centrally. However, the following table shows the number of patients notified to receive isatuximab, in combination with pomalidomide and dexamethasone, in 2021, 2...